| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 0.008 |